- Home
- / Lepu Biopharma
Lepu Biopharma
Stock Price
$2.8
2024-09-17
Market Capitalization
$5 B
2024-09-17
Revenue
¥225.4 M
FY, 2023
Lepu Biopharma Summary
Company Summary
- Overview
- Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics. It develops a pipeline of drug candidates including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
- Type
- Public
- Status
- Active
- Founded
- 2018
- HQ
- HK | view all locations
Table of Contents
Lepu Biopharma Financials
Summary Financials
- Revenue (FY, 2023)
- ¥225.4M
- Gross profit (FY, 2023)
- ¥204.2M
- Net income (FY, 2023)
- (¥30.3M)
- Cash (FY, 2023)
- ¥426.0M
- EBIT (FY, 2023)
- (¥197.5M)
- Enterprise value
- $7.1B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2024